Project Grant R03AI185821
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$146K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $399,100 Project Grant under the Allergy and Infectious Diseases Research Program (CFDA 93.855) to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) Division. This 2-year project will investigate how the pathogen Chlamydia trachomatis manipulates the host cell protein PICALM to facilitate its own replication and survival, while minimizing host cell stress. The research aims...
This Project Grant award of $156,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research by Thomas Jefferson University to characterize the process of homotypic fusion in the bacterium Chlamydia muridarum. The goal is to determine how this fusion process contributes to the virulence and pathogenesis of Chlamydia infections, which are a leading cause of sexually transmitted...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) in the amount of $130,950 to the Regents of the University of Idaho to conduct research on understanding the regulation of gene expression and the function of type III secretion system translocons in the developmental cycle of chlamydial bacteria. The research aims to provide a more complete understanding of the chlamydial developmental cycle, which...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research into the regulation of divisome assembly in the obligate intracellular pathogen Chlamydia trachomatis. The total award is $782,795.00 over a period of 5 years, starting on Jun 17, 2025. The research aims to define the molecular mechanisms that regulate divisome function and the polarized division...
The Applied Research Foundation of West Virginia received a $444,000 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research program) to study the effects of stress on Chlamydia infections in a mouse model. The research aims to define the mechanisms by which stress may suppress the immune system and increase the intensity of Chlamydia genital infection and its associated immunopathologies. Key aspects of the project...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $390,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of Idaho. The grant will fund research to better understand the developmental cycle of chlamydial bacteria, which cause various infectious diseases in humans. Specifically, the project aims to develop a CRISPR-based knockdown screen to assess the role of essential genes in regulating chlamydial...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $775,795 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) division. The grant, effective August 19, 2024 through June 30, 2029, supports research to investigate the functional relevance of polymorphisms in the tryptophan (TRP) operon of the pathogen Chlamydia trachomatis. Key focus...
This $617,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to delineate the molecular function and contributions to species-specific infection biology of putative glycosyltransferase "cytotoxin" proteins in Chlamydia bacteria. The University of Kentucky Research Foundation, the awardee, has applied genetic and biochemical approaches to investigate...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $423,500.00 to investigate the role(s) of chlamydial polymorphic membrane proteins (PMPs) during infection with Chlamydia trachomatis. The award was granted to The University of Kentucky Research Foundation on July 1, 2025 and is set to run through June 30, 2027. The key objectives are to delineate the specific function(s) of PmpI...
This Project Grant award of $242,410 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at the University of Maryland, Baltimore to identify specific features of the vaginal microbiome and immune milieu that contribute to spontaneous clearance of Chlamydia trachomatis (CT) infections. The key objectives are to evaluate associations between (1) bacterial growth rates, (2) Th1 and...